CDER’s Novel Approvals In 2012
This article was originally published in Pharmaceutical Approvals Monthly
The Center for Drug Evaluation and Research cleared 32 new molecular entities and seven novel therapeutic biologics in 2012. The Center for Biologics Evaluation and Research approved six new biologic entities, bringing the total across FDA to 45 new agents.
You may also be interested in...
Cognoa said it will submit its AI-powered digital app for early detection of autism for de novo clearance with the US FDA. See what the company’s senior medical director of clinical adoption said about it here.
Congress should give FDA more flexibility to administer orphan designations, such as the ability to revoke designations later if the disease prevalence grows beyond the rare disease threshold.
In sign of how much has changed in four years, industry might be better off if Biden takes CAP’s advice and launches ‘march-in’ actions to address pricing of COVID products.